Journal article icon

Journal article

Stimulation of insulin release by repaglinide and glibenclamide involves both common and distinct processes.

Abstract:

The action of repaglinide, a novel insulin secretagogue, was compared with the sulfonylurea glibenclamide with regard to the hypoglycemic action in vivo, binding to betaTC-3 cells, insulin secretion from perifused mouse islets, and capacity to stimulate exocytosis by direct interaction with the secretory machinery in single voltage-clamped mouse beta-cells. Two binding sites were identified: a high-affinity repaglinide (KD = 3.6 nmol/l) site having lower affinity for glibenclamide (14.4 nmol/...

Expand abstract
Publication status:
Published

Actions


Access Document


Publisher copy:
10.2337/diabetes.47.3.345

Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, RDM, OCDEM
Role:
Author
Expand authors...
Journal:
Diabetes
Volume:
47
Issue:
3
Pages:
345-351
Publication date:
1998-03-05
DOI:
EISSN:
1939-327X
ISSN:
0012-1797
URN:
uuid:ca4c84d1-ba36-4df9-a900-b7ca8a2c1bc0
Source identifiers:
17318
Local pid:
pubs:17318

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP